LaMiVudine LMV


If you want to support NGYX Non-Profit initiative by advertising on this WEB site Click Here!


Correlated Genos/Phenos Subsets.

LaMiVudine / LMV / R overview.

Remark: Some data relate to Subset#1 (Free) used as an example (1 out of 25). You can access an INFO file with Raw data to analyse and complete the picture. Click HERE.


If you want to catch the Subset#1  Dataset (or even more) Click HERE. 


I. G/Ps Content and Clades Prevalance.

II. Drug Resistance accross G/Ps.

NGYX I.C. Comment(s): A large majority of Phenotypic results (various sources) fail to be discriminative at Resistance side (numerous measurements are over the upper limit of the detection range). That's not a big challenge, just a little bit frustrating as > 90% of these TOORs (Test Out Of Range) measurements are linked to the presence of variants at position RT 184 (I,V,C,...).


III. Additional Remarks.

A. LMV is rated at 50% on the NGYX I.C.Scale of Drug Resistance Interest (DRI). This means that each couple of G/P is valuable maximally for 0.50 Euros. If you want to know more about DRI Click HERE.


B. Combining subsets will impact the number of variables (mutations / clades) that NGIX I.C. classify as "ACCEPTED". T0 know more about this Click HERE.


NGYX I.C. details / Coordinates.

Company N°: BE 0537.471.159

Postal Adress:  NGYX I.C. (P. LECOCQ ),rue des Hausseurs 10, B-4550 Nandrin, BELGIUM. Email:  Info@NGYX.EU              Tel. / GSM: +32 498 532496 IBAN: BE63 7506 5746 0708 BIC: AXABBE22

Email  us: Click Here!